174 related articles for article (PubMed ID: 29207651)
1. Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.
Wang J; Ye C; Lu D; Chen Y; Jia Y; Ying X; Xiong H; Zhao W; Zhou J; Wang L
Oncotarget; 2017 Oct; 8(53):91379-91390. PubMed ID: 29207651
[TBL] [Abstract][Full Text] [Related]
2. An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
Xia H; Yu W; Liu M; Li H; Pang W; Wang L; Zhang Y
Oncol Lett; 2019 Sep; 18(3):2985-2994. PubMed ID: 31452777
[TBL] [Abstract][Full Text] [Related]
3. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
Wu HT; Liu J; Li GW; Shen JX; Huang YT
Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients.
Gu S; Chu C; Chen W; Ren H; Cao Y; Li X; He J; Wang Y; Jin Y; Liu X; Zou Q
Int J Clin Exp Pathol; 2019; 12(6):2009-2021. PubMed ID: 31934023
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
Pietruszewska W; Bojanowska-Poźniak K; Kobos J
Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis revealing prognostic significance of
Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
[No Abstract] [Full Text] [Related]
10. Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer.
Cui X; Jing X; Yi Q; Long C; Tian J; Zhu J
Oncotarget; 2017 Dec; 8(67):111444-111455. PubMed ID: 29340066
[TBL] [Abstract][Full Text] [Related]
11. SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
Huo Q; Li Z; Cheng L; Yang F; Xie N
Front Oncol; 2020; 10():621. PubMed ID: 32528869
[No Abstract] [Full Text] [Related]
12. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.
Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T
Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
14. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer.
Liu Y; Pan B; Qu W; Cao Y; Li J; Zhao H
Cancer Cell Int; 2021 Feb; 21(1):130. PubMed ID: 33622332
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Significances of Cancer Stem Cell-Associated HHEX Expression in Breast Cancer.
Zhang K; Zhao Q; Li Z; Fu F; Zhang H; Fu J; Zheng M; Zhang S
Front Cell Dev Biol; 2020; 8():605744. PubMed ID: 33425911
[TBL] [Abstract][Full Text] [Related]
17. Mining the prognostic significance of the GINS2 gene in human breast cancer using bioinformatics analysis.
Yu S; Zhu L; Xie P; Jiang S; Wang K; Liu Y; He J; Ren Y
Oncol Lett; 2020 Aug; 20(2):1300-1310. PubMed ID: 32724372
[TBL] [Abstract][Full Text] [Related]
18. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
19. Identification of endothelial selectin as a potential prognostic marker in breast cancer.
Zhang W; Zuo Z; Huang X; Liu J; Jin G; Su D
Oncol Lett; 2018 Jun; 15(6):9908-9916. PubMed ID: 29928363
[TBL] [Abstract][Full Text] [Related]
20. Expressions and prognostic values of the
Liu ZL; Bi XW; Liu PP; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
Cancer Manag Res; 2018; 10():3521-3532. PubMed ID: 30271201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
